Zoetis (NYSE:ZTS) Price Target Raised to $200.00 at Stifel Nicolaus

Zoetis (NYSE:ZTS) had its price target hoisted by Stifel Nicolaus from $180.00 to $200.00 in a research report sent to investors on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock.

Other equities analysts also recently issued reports about the company. Barclays lowered their price objective on Zoetis from $260.00 to $230.00 and set an overweight rating on the stock in a research report on Tuesday, April 23rd. HSBC dropped their price target on Zoetis from $230.00 to $225.00 and set a buy rating for the company in a research note on Wednesday, May 8th. Piper Sandler reiterated an overweight rating and set a $195.00 price objective (down previously from $220.00) on shares of Zoetis in a research report on Tuesday, April 16th. The Goldman Sachs Group decreased their price target on shares of Zoetis from $223.00 to $196.00 and set a buy rating on the stock in a research note on Monday, May 6th. Finally, BTIG Research assumed coverage on Zoetis in a research report on Thursday, July 25th. They set a buy rating and a $220.00 price objective for the company. Nine analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has a consensus rating of Buy and a consensus target price of $214.89.

Zoetis Price Performance

Shares of ZTS stock traded up $10.47 on Monday, hitting $185.29. 3,740,654 shares of the stock traded hands, compared to its average volume of 2,807,865. The company has a debt-to-equity ratio of 1.30, a current ratio of 3.33 and a quick ratio of 1.94. Zoetis has a 52 week low of $144.80 and a 52 week high of $201.92. The firm has a 50 day simple moving average of $175.53 and a two-hundred day simple moving average of $175.38. The firm has a market cap of $84.55 billion, a price-to-earnings ratio of 36.44, a PEG ratio of 2.80 and a beta of 0.86.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 4th. Investors of record on Thursday, July 18th will be issued a dividend of $0.432 per share. The ex-dividend date is Thursday, July 18th. This represents a $1.73 annualized dividend and a yield of 0.93%. Zoetis’s payout ratio is 33.33%.

Institutional Investors Weigh In On Zoetis

Hedge funds and other institutional investors have recently modified their holdings of the business. Blue Bell Private Wealth Management LLC increased its stake in Zoetis by 222.5% in the fourth quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock worth $25,000 after purchasing an additional 89 shares during the period. Private Wealth Management Group LLC purchased a new stake in Zoetis in the fourth quarter worth about $33,000. Webster Bank N. A. grew its holdings in Zoetis by 89.1% during the 1st quarter. Webster Bank N. A. now owns 174 shares of the company’s stock worth $29,000 after acquiring an additional 82 shares in the last quarter. Gladius Capital Management LP purchased a new position in Zoetis during the 4th quarter valued at about $40,000. Finally, Neo Ivy Capital Management purchased a new position in Zoetis during the 4th quarter valued at about $40,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.